Johanne Martel-Pelletier was born on 20th April, 1952 in Saint-Jean, Quebec, Canada. She earned her Master’s and Ph.D. degrees in Physiology from the University of Montreal, in 1975 and 1979, respectively, and completed her training first in biophysics at the University of Montreal in 1979, then in rheumatology at the University of Miami, Fl (USA) in 1981. She was appointed Assistant Professor of Medicine at the University of Montreal in 1981 and became Associate Professor in 1989 and full Professor in 1995. She is the Co-Director of the Osteoarthritis Research Unit at the Notre-Dame Hospital of the University of Montreal Hospital Center, which she co-founded with Jean-Pierre Pelletier in 1981.
Professor Martel-Pelletier’s research, jointly with Professor Jean-Pierre Pelletier, focuses on understanding the mechanisms involved in the pathophysiology of osteoarthritis, as well as on investigating and developing new therapeutic strategies for the treatment of osteoarthritis. She is an active member of several editorial boards and committees and is a highly respected reviewer for many rheumatology and connective tissue journals, and governmental and private research funding agencies.
In recognition of her excellence in osteoarthritis research, Professor Johanne Martel-Pelletier was awarded a number of fellowships and prizes including ILAR Rheumatology Prize, the International Carol-Nachman Award for Rheumatology, Personality of the Week, La Presse, Montreal and the EULAR Scientific Award for Basic Research in Osteoarthritis, in addition to the King Faisal International Prize for Medicine.
She authored about 240 refereed journal articles, 26 books or book chapters, 37 reviews or editorials and 530 abstracts, and has given 155 invited lectures.
Professors Jean Pelletier and Johanne Pelletier have contributed substantially to translational research in the field of osteoarthritis. Their original work has led to major discoveries in the pathophysiology of osteoarthritis, particularly joint catabolism and repair. These studies have paved the way to identification of therapeutic targets. In addition they develop an innovative technology for the quantitative assessment of changes and alteration in cartilage and other articular tissues.